PREMIER BIOMEDICAL SEEKS JOINT VENTURE PARTNERS.

 
FREE EXCERPT

Premier Biomedical, Inc. has engaged the services of an agent affiliated with the Chinese pharmaceutical industry to seek out suitable joint venture partners in China and Europe. The agent will act in Premier's interests in locating and securing financing and suitable joint venture partners in China and Europe for the purposes of testing, registering and marketing medications and devices being developed by Premier for the treatment of various diseases, such as fibromyalgia, MS, and cancer.

William A. Hartman, President and CEO of Premier Biomedical, stated, We believe there are significant advantages in seeking a joint venture with Chinese and European biomedical/pharmaceutical partners, and see this as the next step to expanding our potential market coverage. This effort does not lessen the importance of securing similar JV arrangements in Brazil, India, and the rest of Asia, but, in fact, complements those efforts.

About Premier Biomedical, Inc.

Premier Biomedical, Inc. (OTCQB: BIEI) is a biotech research public company focused on...

To continue reading

FREE SIGN UP